Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest Morphine Stories

2012-05-17 10:25:19

RARITAN, N.J., May 17, 2012 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. today announced the results of an investigational Phase 3 study suggesting NUCYNTA® ER (tapentadol) extended-release tablets were significantly more effective than placebo in providing pain management among adults with chronic moderate to severe, painful diabetic peripheral neuropathy (DPN). Results of the study were presented at the 31st Annual Scientific Meeting of the American Pain Society being held May 16-19 in...

2012-05-02 02:27:26

SAN DIEGO, May 2, 2012 /PRNewswire/ -- Zogenix, Inc. (NASDAQ: ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, announced today that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Zohydro(TM) (hydrocodone bitartrate extended-release capsules), Zogenix's lead investigational product candidate for the treatment of chronic pain. Zohydro is a novel,...

2012-04-30 02:26:12

BEDMINSTER, N.J., April 30, 2012 /PRNewswire-USNewswire/ -- During this year's Drug and Delivery Formulations Summit (San Diego, CA) Grunenthal presents its new INTAC(TM) formulation technology designed to be crush-resistant and to protect intended action of extended release prescription opioid drugs. Prescription opioids are at the center of a major public health crisis of misuse and abuse in the United States. Prescription drug abuse is the fastest-growing drug problem in the U.S....

2012-04-25 10:25:52

BEVERLY HILLS, Calif., April 25, 2012 /PRNewswire/ -- Following a new report released today by the National Survey on Drug Use and Health, Administrative Director for WAISMANN METHOD® rapid detox treatment and Registered Addiction Specialist, Clare Waismann, is urging all Americans to turn in their unused, unwanted, or expired prescription painkiller medications on National Take-Back Day, April 28, 2012. The new government report based on data from 2009 to 2010, indicates that...

2012-04-23 23:00:49

Former NBA Star Chris Herren´s message of hope and perserverence in a triumphant battle with the scourge of drug addiction has captured the imagination of young people across the country. Once one of the most highly touted Division 1 basketball prospects ever to emerge from the Northeast, Herren lost it all to cocaine, oxycodone, and heroin addictions, then clawed his way back from the brink of death to fashion a new life as an exemplar of courage and generosity. Now Chris Herren will...

2012-04-23 21:20:09

Patients with advanced chronic obstructive pulmonary disease (COPD) and shortness of breath found that opioids provided relief and improved their quality of life, states an article in CMAJ (Canadian Medical Association Journal). However, physicians are reluctant to prescribe opioids for this condition, meaning many people will not benefit from this treatment. The prevalence of COPD in Canada is increasing, and shortness of breath (dyspnea) is a major symptom that is difficult to treat and...

2012-04-18 13:42:36

Strong associations with circulatory diseases, respiratory conditions and cancer Long term opium use, even in relatively low doses, is associated with almost double the risk of death from many causes, particularly circulatory diseases, respiratory conditions and cancer, concludes a study published on bmj.com today. The findings remind us not only that opium is harmful, but raise questions about the risks of long term prescription opioids for treatment of chronic pain. The research...

2012-04-16 02:28:32

Hanley Center Survey Finds Depression and Anxiety Fuel Addiction Among Older Americans WEST PALM BEACH, Fla., April 16, 2012 /PRNewswire-USNewswire/ -- The number of people over the age of 50 who are being treated for addiction is drastically on the rise. According to the Substance Abuse and Mental Health Services Administration older adults who reported using illegal drugs within a year, nearly doubled between 2002 and 2007, while use of nonmedical pharmaceuticals increased from 2.2% in...

2012-04-12 02:38:11

REDWOOD CITY, Calif., April 12, 2012 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today reported dosing of the first patient in the second of three planned Phase 3 studies that will form the basis of a planned New Drug Application (NDA) for the Sufentanil NanoTab® PCA System, ARX-01. Utilizing a...

2012-04-10 14:22:32

BEDMINSTER, N.J. and SYDNEY, April 10, 2012 /PRNewswire/ -- QRxPharma (ASX: QRX and OTCQX: QRXPY) announced today successful completion of two Phase 1 studies in healthy volunteers for MoxDuo® CR, a controlled-release Dual-Opioid® utilising a 3:2 ratio of morphine and oxycodone. The proprietary MoxDuo CR formulation, encompassing both sustained delivery technology as well as abuse deterrent and tamper resistant features, is designed to provide at least 12 hours of analgesia in...